Even though MFN1 expression levels in breast cancer also correlate with worse prognosis, our data indicate that MFN1 or MFN2 deletion does not affect breast cancer cells migration, proliferation, or adhesion. This evidence concerns the gene MFN1 and breast carcinoma.